nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—ABCB1—ulcerative colitis	0.156	1	CbGaD
Regorafenib—ABCG2—Sulfasalazine—ulcerative colitis	0.0326	0.0743	CbGbCtD
Regorafenib—CYP2B6—Nicotine—ulcerative colitis	0.0295	0.0672	CbGbCtD
Regorafenib—CYP2B6—Cholecalciferol—ulcerative colitis	0.0264	0.0603	CbGbCtD
Regorafenib—ABCG2—Hydrocortisone—ulcerative colitis	0.0261	0.0596	CbGbCtD
Regorafenib—CYP2C8—Nicotine—ulcerative colitis	0.0223	0.0509	CbGbCtD
Regorafenib—CYP3A4—Budesonide—ulcerative colitis	0.0208	0.0474	CbGbCtD
Regorafenib—CYP2C8—Cholecalciferol—ulcerative colitis	0.02	0.0456	CbGbCtD
Regorafenib—RET—enteric nervous system—ulcerative colitis	0.0189	0.189	CbGeAlD
Regorafenib—CYP2C19—Nicotine—ulcerative colitis	0.0187	0.0427	CbGbCtD
Regorafenib—CYP2C19—Cholecalciferol—ulcerative colitis	0.0168	0.0383	CbGbCtD
Regorafenib—ABCG2—Dexamethasone—ulcerative colitis	0.0163	0.0371	CbGbCtD
Regorafenib—CYP2C9—Nicotine—ulcerative colitis	0.0156	0.0355	CbGbCtD
Regorafenib—ABCB1—Methylprednisolone—ulcerative colitis	0.0155	0.0353	CbGbCtD
Regorafenib—CYP2C9—Cholecalciferol—ulcerative colitis	0.014	0.0318	CbGbCtD
Regorafenib—CYP2C8—Hydrocortisone—ulcerative colitis	0.0139	0.0318	CbGbCtD
Regorafenib—CYP2C19—Prednisone—ulcerative colitis	0.0116	0.0265	CbGbCtD
Regorafenib—CYP2B6—Dexamethasone—ulcerative colitis	0.0114	0.0261	CbGbCtD
Regorafenib—ABCB1—Betamethasone—ulcerative colitis	0.0101	0.023	CbGbCtD
Regorafenib—ABCB1—Prednisolone—ulcerative colitis	0.00995	0.0227	CbGbCtD
Regorafenib—KIT—myenteric nerve plexus—ulcerative colitis	0.00947	0.0947	CbGeAlD
Regorafenib—ABCB1—Hydrocortisone—ulcerative colitis	0.00943	0.0215	CbGbCtD
Regorafenib—ABCB1—Prednisone—ulcerative colitis	0.00939	0.0214	CbGbCtD
Regorafenib—CYP3A4—Methylprednisolone—ulcerative colitis	0.00929	0.0212	CbGbCtD
Regorafenib—CYP3A4—Nicotine—ulcerative colitis	0.00905	0.0206	CbGbCtD
Regorafenib—CYP2C8—Dexamethasone—ulcerative colitis	0.00866	0.0198	CbGbCtD
Regorafenib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00812	0.0185	CbGbCtD
Regorafenib—CYP2C19—Dexamethasone—ulcerative colitis	0.00727	0.0166	CbGbCtD
Regorafenib—CYP3A4—Triamcinolone—ulcerative colitis	0.00704	0.0161	CbGbCtD
Regorafenib—CYP2C9—Dexamethasone—ulcerative colitis	0.00604	0.0138	CbGbCtD
Regorafenib—CYP3A4—Betamethasone—ulcerative colitis	0.00604	0.0138	CbGbCtD
Regorafenib—CYP3A4—Prednisolone—ulcerative colitis	0.00596	0.0136	CbGbCtD
Regorafenib—ABCB1—Dexamethasone—ulcerative colitis	0.00586	0.0134	CbGbCtD
Regorafenib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00565	0.0129	CbGbCtD
Regorafenib—CYP3A4—Prednisone—ulcerative colitis	0.00563	0.0128	CbGbCtD
Regorafenib—CYP3A4—Dexamethasone—ulcerative colitis	0.00351	0.00801	CbGbCtD
Regorafenib—DDR2—smooth muscle tissue—ulcerative colitis	0.00256	0.0256	CbGeAlD
Regorafenib—FRK—lymphoid tissue—ulcerative colitis	0.00228	0.0228	CbGeAlD
Regorafenib—DDR2—lymphoid tissue—ulcerative colitis	0.00205	0.0205	CbGeAlD
Regorafenib—DDR2—digestive system—ulcerative colitis	0.00202	0.0202	CbGeAlD
Regorafenib—FRK—liver—ulcerative colitis	0.00168	0.0168	CbGeAlD
Regorafenib—FLT4—epithelium—ulcerative colitis	0.00162	0.0162	CbGeAlD
Regorafenib—DDR2—liver—ulcerative colitis	0.00151	0.0151	CbGeAlD
Regorafenib—RET—epithelium—ulcerative colitis	0.00143	0.0143	CbGeAlD
Regorafenib—FGFR2—epithelium—ulcerative colitis	0.00136	0.0136	CbGeAlD
Regorafenib—EPHA2—epithelium—ulcerative colitis	0.00133	0.0133	CbGeAlD
Regorafenib—FGFR2—smooth muscle tissue—ulcerative colitis	0.00131	0.0131	CbGeAlD
Regorafenib—TEK—epithelium—ulcerative colitis	0.0013	0.013	CbGeAlD
Regorafenib—FLT1—epithelium—ulcerative colitis	0.00126	0.0126	CbGeAlD
Regorafenib—TEK—smooth muscle tissue—ulcerative colitis	0.00125	0.0125	CbGeAlD
Regorafenib—RAF1—epithelium—ulcerative colitis	0.00125	0.0125	CbGeAlD
Regorafenib—UGT1A9—digestive system—ulcerative colitis	0.00125	0.0125	CbGeAlD
Regorafenib—FLT4—lymphoid tissue—ulcerative colitis	0.00125	0.0125	CbGeAlD
Regorafenib—FLT1—smooth muscle tissue—ulcerative colitis	0.00121	0.0121	CbGeAlD
Regorafenib—RAF1—smooth muscle tissue—ulcerative colitis	0.00121	0.0121	CbGeAlD
Regorafenib—PDGFRA—smooth muscle tissue—ulcerative colitis	0.00114	0.0114	CbGeAlD
Regorafenib—RET—lymphoid tissue—ulcerative colitis	0.0011	0.011	CbGeAlD
Regorafenib—RET—digestive system—ulcerative colitis	0.00109	0.0109	CbGeAlD
Regorafenib—BRAF—liver—ulcerative colitis	0.00106	0.0106	CbGeAlD
Regorafenib—KDR—epithelium—ulcerative colitis	0.00106	0.0106	CbGeAlD
Regorafenib—FGFR2—digestive system—ulcerative colitis	0.00103	0.0103	CbGeAlD
Regorafenib—EPHA2—lymphoid tissue—ulcerative colitis	0.00103	0.0103	CbGeAlD
Regorafenib—KDR—smooth muscle tissue—ulcerative colitis	0.00102	0.0103	CbGeAlD
Regorafenib—EPHX2—liver—ulcerative colitis	0.00102	0.0102	CbGeAlD
Regorafenib—EPHA2—digestive system—ulcerative colitis	0.00101	0.0102	CbGeAlD
Regorafenib—TEK—lymphoid tissue—ulcerative colitis	0.001	0.01	CbGeAlD
Regorafenib—FLT1—lymphoid tissue—ulcerative colitis	0.000969	0.00969	CbGeAlD
Regorafenib—RAF1—lymphoid tissue—ulcerative colitis	0.000963	0.00964	CbGeAlD
Regorafenib—FLT1—digestive system—ulcerative colitis	0.000957	0.00958	CbGeAlD
Regorafenib—RAF1—digestive system—ulcerative colitis	0.000952	0.00952	CbGeAlD
Regorafenib—KIT—epithelium—ulcerative colitis	0.000943	0.00943	CbGeAlD
Regorafenib—UGT1A9—liver—ulcerative colitis	0.00093	0.00931	CbGeAlD
Regorafenib—PDGFRB—epithelium—ulcerative colitis	0.000921	0.00921	CbGeAlD
Regorafenib—FLT4—liver—ulcerative colitis	0.000917	0.00918	CbGeAlD
Regorafenib—KIT—smooth muscle tissue—ulcerative colitis	0.000908	0.00909	CbGeAlD
Regorafenib—PDGFRA—lymphoid tissue—ulcerative colitis	0.000908	0.00908	CbGeAlD
Regorafenib—FGFR1—liver—ulcerative colitis	0.000905	0.00905	CbGeAlD
Regorafenib—PDGFRA—digestive system—ulcerative colitis	0.000897	0.00897	CbGeAlD
Regorafenib—PDGFRB—smooth muscle tissue—ulcerative colitis	0.000887	0.00887	CbGeAlD
Regorafenib—UGT1A1—digestive system—ulcerative colitis	0.000856	0.00856	CbGeAlD
Regorafenib—KDR—lymphoid tissue—ulcerative colitis	0.000819	0.0082	CbGeAlD
Regorafenib—KDR—digestive system—ulcerative colitis	0.000809	0.0081	CbGeAlD
Regorafenib—ABL1—smooth muscle tissue—ulcerative colitis	0.000791	0.00791	CbGeAlD
Regorafenib—FGFR2—liver—ulcerative colitis	0.000769	0.0077	CbGeAlD
Regorafenib—EPHA2—liver—ulcerative colitis	0.000756	0.00756	CbGeAlD
Regorafenib—TEK—liver—ulcerative colitis	0.000738	0.00738	CbGeAlD
Regorafenib—KIT—lymphoid tissue—ulcerative colitis	0.000726	0.00726	CbGeAlD
Regorafenib—KIT—digestive system—ulcerative colitis	0.000717	0.00717	CbGeAlD
Regorafenib—FLT1—liver—ulcerative colitis	0.000713	0.00713	CbGeAlD
Regorafenib—PDGFRB—lymphoid tissue—ulcerative colitis	0.000709	0.00709	CbGeAlD
Regorafenib—RAF1—liver—ulcerative colitis	0.000709	0.00709	CbGeAlD
Regorafenib—PDGFRB—digestive system—ulcerative colitis	0.0007	0.00701	CbGeAlD
Regorafenib—PDGFRA—liver—ulcerative colitis	0.000668	0.00669	CbGeAlD
Regorafenib—UGT1A1—liver—ulcerative colitis	0.000638	0.00638	CbGeAlD
Regorafenib—ABL1—lymphoid tissue—ulcerative colitis	0.000632	0.00632	CbGeAlD
Regorafenib—ABL1—digestive system—ulcerative colitis	0.000624	0.00625	CbGeAlD
Regorafenib—KDR—liver—ulcerative colitis	0.000603	0.00603	CbGeAlD
Regorafenib—KIT—liver—ulcerative colitis	0.000534	0.00534	CbGeAlD
Regorafenib—PDGFRB—liver—ulcerative colitis	0.000522	0.00522	CbGeAlD
Regorafenib—ABL1—liver—ulcerative colitis	0.000465	0.00465	CbGeAlD
Regorafenib—CYP2C19—digestive system—ulcerative colitis	0.000464	0.00464	CbGeAlD
Regorafenib—CYP2B6—lymphoid tissue—ulcerative colitis	0.000368	0.00368	CbGeAlD
Regorafenib—CYP2B6—digestive system—ulcerative colitis	0.000363	0.00363	CbGeAlD
Regorafenib—CYP2C9—digestive system—ulcerative colitis	0.00036	0.0036	CbGeAlD
Regorafenib—CYP2C19—liver—ulcerative colitis	0.000346	0.00346	CbGeAlD
Regorafenib—Connective tissue disorder—Mesalazine—ulcerative colitis	0.000337	0.00273	CcSEcCtD
Regorafenib—Urethral disorder—Mesalazine—ulcerative colitis	0.000336	0.00272	CcSEcCtD
Regorafenib—Alopecia—Azathioprine—ulcerative colitis	0.000333	0.00269	CcSEcCtD
Regorafenib—Dry skin—Prednisolone—ulcerative colitis	0.000331	0.00268	CcSEcCtD
Regorafenib—Erythema multiforme—Mesalazine—ulcerative colitis	0.000325	0.00263	CcSEcCtD
Regorafenib—Dry skin—Hydrocortisone—ulcerative colitis	0.000323	0.00262	CcSEcCtD
Regorafenib—Hypokalaemia—Hydrocortisone—ulcerative colitis	0.000321	0.0026	CcSEcCtD
Regorafenib—Cardiac disorder—Mesalazine—ulcerative colitis	0.000319	0.00258	CcSEcCtD
Regorafenib—Hypertension—Budesonide—ulcerative colitis	0.000317	0.00257	CcSEcCtD
Regorafenib—Asthenia—Nicotine—ulcerative colitis	0.000312	0.00253	CcSEcCtD
Regorafenib—Angiopathy—Mesalazine—ulcerative colitis	0.000311	0.00252	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Hydrocortisone—ulcerative colitis	0.000311	0.00252	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000311	0.00251	CcSEcCtD
Regorafenib—Mediastinal disorder—Mesalazine—ulcerative colitis	0.000309	0.0025	CcSEcCtD
Regorafenib—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000307	0.00249	CcSEcCtD
Regorafenib—Dry mouth—Budesonide—ulcerative colitis	0.000306	0.00247	CcSEcCtD
Regorafenib—Alopecia—Mesalazine—ulcerative colitis	0.000303	0.00245	CcSEcCtD
Regorafenib—Anaemia—Azathioprine—ulcerative colitis	0.000303	0.00245	CcSEcCtD
Regorafenib—CYP2C8—liver—ulcerative colitis	0.000302	0.00302	CbGeAlD
Regorafenib—Diarrhoea—Nicotine—ulcerative colitis	0.000298	0.00241	CcSEcCtD
Regorafenib—Infection—Budesonide—ulcerative colitis	0.000298	0.00241	CcSEcCtD
Regorafenib—Nervous system disorder—Budesonide—ulcerative colitis	0.000294	0.00238	CcSEcCtD
Regorafenib—Leukopenia—Azathioprine—ulcerative colitis	0.000294	0.00238	CcSEcCtD
Regorafenib—ABCG2—liver—ulcerative colitis	0.000293	0.00293	CbGeAlD
Regorafenib—Alanine aminotransferase increased—Methylprednisolone—ulcerative colitis	0.000292	0.00236	CcSEcCtD
Regorafenib—Skin disorder—Budesonide—ulcerative colitis	0.000291	0.00236	CcSEcCtD
Regorafenib—Vomiting—Mercaptopurine—ulcerative colitis	0.000286	0.00231	CcSEcCtD
Regorafenib—Rash—Mercaptopurine—ulcerative colitis	0.000283	0.00229	CcSEcCtD
Regorafenib—Dermatitis—Mercaptopurine—ulcerative colitis	0.000283	0.00229	CcSEcCtD
Regorafenib—Tremor—Mesalazine—ulcerative colitis	0.00028	0.00226	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000277	0.00224	CcSEcCtD
Regorafenib—Vomiting—Nicotine—ulcerative colitis	0.000277	0.00224	CcSEcCtD
Regorafenib—Dry skin—Dexamethasone—ulcerative colitis	0.000276	0.00224	CcSEcCtD
Regorafenib—Dry skin—Betamethasone—ulcerative colitis	0.000276	0.00224	CcSEcCtD
Regorafenib—Anaemia—Mesalazine—ulcerative colitis	0.000276	0.00223	CcSEcCtD
Regorafenib—Weight decreased—Hydrocortisone—ulcerative colitis	0.000276	0.00223	CcSEcCtD
Regorafenib—Rash—Nicotine—ulcerative colitis	0.000274	0.00222	CcSEcCtD
Regorafenib—Acute coronary syndrome—Prednisolone—ulcerative colitis	0.000274	0.00222	CcSEcCtD
Regorafenib—Hypokalaemia—Dexamethasone—ulcerative colitis	0.000274	0.00222	CcSEcCtD
Regorafenib—Hypokalaemia—Betamethasone—ulcerative colitis	0.000274	0.00222	CcSEcCtD
Regorafenib—CYP3A4—digestive system—ulcerative colitis	0.000274	0.00274	CbGeAlD
Regorafenib—Dermatitis—Nicotine—ulcerative colitis	0.000274	0.00222	CcSEcCtD
Regorafenib—Myocardial infarction—Prednisolone—ulcerative colitis	0.000273	0.00221	CcSEcCtD
Regorafenib—Headache—Nicotine—ulcerative colitis	0.000273	0.00221	CcSEcCtD
Regorafenib—Infestation—Hydrocortisone—ulcerative colitis	0.000272	0.0022	CcSEcCtD
Regorafenib—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000272	0.0022	CcSEcCtD
Regorafenib—CYP2B6—liver—ulcerative colitis	0.000271	0.00271	CbGeAlD
Regorafenib—Acute coronary syndrome—Hydrocortisone—ulcerative colitis	0.000268	0.00217	CcSEcCtD
Regorafenib—CYP2C9—liver—ulcerative colitis	0.000268	0.00268	CbGeAlD
Regorafenib—Leukopenia—Mesalazine—ulcerative colitis	0.000267	0.00216	CcSEcCtD
Regorafenib—Nausea—Mercaptopurine—ulcerative colitis	0.000267	0.00216	CcSEcCtD
Regorafenib—Myocardial infarction—Hydrocortisone—ulcerative colitis	0.000266	0.00216	CcSEcCtD
Regorafenib—Infection—Azathioprine—ulcerative colitis	0.000266	0.00215	CcSEcCtD
Regorafenib—Thrombocytopenia—Azathioprine—ulcerative colitis	0.000262	0.00212	CcSEcCtD
Regorafenib—Decreased appetite—Budesonide—ulcerative colitis	0.000261	0.00211	CcSEcCtD
Regorafenib—Skin disorder—Azathioprine—ulcerative colitis	0.00026	0.0021	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000259	0.00209	CcSEcCtD
Regorafenib—Nausea—Nicotine—ulcerative colitis	0.000259	0.00209	CcSEcCtD
Regorafenib—Fatigue—Budesonide—ulcerative colitis	0.000258	0.00209	CcSEcCtD
Regorafenib—Hypertension—Mesalazine—ulcerative colitis	0.000258	0.00209	CcSEcCtD
Regorafenib—Pain—Budesonide—ulcerative colitis	0.000256	0.00207	CcSEcCtD
Regorafenib—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000255	0.00207	CcSEcCtD
Regorafenib—Infestation—Methylprednisolone—ulcerative colitis	0.000255	0.00207	CcSEcCtD
Regorafenib—ABCB1—epithelium—ulcerative colitis	0.000255	0.00255	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000253	0.00204	CcSEcCtD
Regorafenib—Acute coronary syndrome—Triamcinolone—ulcerative colitis	0.000252	0.00204	CcSEcCtD
Regorafenib—Acute coronary syndrome—Methylprednisolone—ulcerative colitis	0.000252	0.00204	CcSEcCtD
Regorafenib—Haemoglobin—Prednisolone—ulcerative colitis	0.000251	0.00203	CcSEcCtD
Regorafenib—Myocardial infarction—Triamcinolone—ulcerative colitis	0.000251	0.00203	CcSEcCtD
Regorafenib—Myocardial infarction—Methylprednisolone—ulcerative colitis	0.00025	0.00203	CcSEcCtD
Regorafenib—Haemorrhage—Prednisolone—ulcerative colitis	0.00025	0.00202	CcSEcCtD
Regorafenib—Dry mouth—Mesalazine—ulcerative colitis	0.000249	0.00201	CcSEcCtD
Regorafenib—Haemoglobin—Hydrocortisone—ulcerative colitis	0.000245	0.00198	CcSEcCtD
Regorafenib—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000245	0.00198	CcSEcCtD
Regorafenib—Haemorrhage—Hydrocortisone—ulcerative colitis	0.000244	0.00197	CcSEcCtD
Regorafenib—Infection—Mesalazine—ulcerative colitis	0.000242	0.00196	CcSEcCtD
Regorafenib—Dry skin—Prednisone—ulcerative colitis	0.000241	0.00195	CcSEcCtD
Regorafenib—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.00024	0.00194	CcSEcCtD
Regorafenib—Nervous system disorder—Mesalazine—ulcerative colitis	0.000239	0.00193	CcSEcCtD
Regorafenib—Hypokalaemia—Prednisone—ulcerative colitis	0.000239	0.00193	CcSEcCtD
Regorafenib—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000239	0.00193	CcSEcCtD
Regorafenib—Body temperature increased—Budesonide—ulcerative colitis	0.000237	0.00192	CcSEcCtD
Regorafenib—Abdominal pain—Budesonide—ulcerative colitis	0.000237	0.00192	CcSEcCtD
Regorafenib—Skin disorder—Mesalazine—ulcerative colitis	0.000237	0.00192	CcSEcCtD
Regorafenib—Weight decreased—Betamethasone—ulcerative colitis	0.000236	0.00191	CcSEcCtD
Regorafenib—Weight decreased—Dexamethasone—ulcerative colitis	0.000236	0.00191	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000232	0.00187	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000231	0.00187	CcSEcCtD
Regorafenib—Haemoglobin—Triamcinolone—ulcerative colitis	0.000231	0.00187	CcSEcCtD
Regorafenib—Haemoglobin—Methylprednisolone—ulcerative colitis	0.00023	0.00186	CcSEcCtD
Regorafenib—Haemorrhage—Triamcinolone—ulcerative colitis	0.00023	0.00186	CcSEcCtD
Regorafenib—Haemorrhage—Methylprednisolone—ulcerative colitis	0.000229	0.00186	CcSEcCtD
Regorafenib—Acute coronary syndrome—Dexamethasone—ulcerative colitis	0.000229	0.00185	CcSEcCtD
Regorafenib—Acute coronary syndrome—Betamethasone—ulcerative colitis	0.000229	0.00185	CcSEcCtD
Regorafenib—Myocardial infarction—Dexamethasone—ulcerative colitis	0.000228	0.00184	CcSEcCtD
Regorafenib—Myocardial infarction—Betamethasone—ulcerative colitis	0.000228	0.00184	CcSEcCtD
Regorafenib—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000225	0.00182	CcSEcCtD
Regorafenib—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000219	0.00177	CcSEcCtD
Regorafenib—Asthenia—Budesonide—ulcerative colitis	0.000215	0.00174	CcSEcCtD
Regorafenib—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000213	0.00172	CcSEcCtD
Regorafenib—Malnutrition—Hydrocortisone—ulcerative colitis	0.000212	0.00172	CcSEcCtD
Regorafenib—Neutropenia—Prednisone—ulcerative colitis	0.000212	0.00172	CcSEcCtD
Regorafenib—Decreased appetite—Mesalazine—ulcerative colitis	0.000212	0.00171	CcSEcCtD
Regorafenib—Abdominal pain—Azathioprine—ulcerative colitis	0.000212	0.00171	CcSEcCtD
Regorafenib—Body temperature increased—Azathioprine—ulcerative colitis	0.000212	0.00171	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000211	0.0017	CcSEcCtD
Regorafenib—Fatigue—Mesalazine—ulcerative colitis	0.00021	0.0017	CcSEcCtD
Regorafenib—Haemoglobin—Betamethasone—ulcerative colitis	0.00021	0.0017	CcSEcCtD
Regorafenib—Haemoglobin—Dexamethasone—ulcerative colitis	0.00021	0.0017	CcSEcCtD
Regorafenib—Pain—Mesalazine—ulcerative colitis	0.000209	0.00169	CcSEcCtD
Regorafenib—Haemorrhage—Betamethasone—ulcerative colitis	0.000209	0.00169	CcSEcCtD
Regorafenib—Haemorrhage—Dexamethasone—ulcerative colitis	0.000209	0.00169	CcSEcCtD
Regorafenib—Angiopathy—Methylprednisolone—ulcerative colitis	0.000208	0.00168	CcSEcCtD
Regorafenib—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000207	0.00167	CcSEcCtD
Regorafenib—Weight decreased—Prednisone—ulcerative colitis	0.000205	0.00166	CcSEcCtD
Regorafenib—Diarrhoea—Budesonide—ulcerative colitis	0.000205	0.00166	CcSEcCtD
Regorafenib—CYP3A4—liver—ulcerative colitis	0.000204	0.00204	CbGeAlD
Regorafenib—Malnutrition—Methylprednisolone—ulcerative colitis	0.0002	0.00161	CcSEcCtD
Regorafenib—Acute coronary syndrome—Prednisone—ulcerative colitis	0.000199	0.00161	CcSEcCtD
Regorafenib—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000199	0.00161	CcSEcCtD
Regorafenib—Myocardial infarction—Prednisone—ulcerative colitis	0.000198	0.0016	CcSEcCtD
Regorafenib—ABCB1—lymphoid tissue—ulcerative colitis	0.000197	0.00197	CbGeAlD
Regorafenib—ABCB1—digestive system—ulcerative colitis	0.000194	0.00194	CbGeAlD
Regorafenib—Body temperature increased—Mesalazine—ulcerative colitis	0.000193	0.00156	CcSEcCtD
Regorafenib—Abdominal pain—Mesalazine—ulcerative colitis	0.000193	0.00156	CcSEcCtD
Regorafenib—Vomiting—Budesonide—ulcerative colitis	0.000191	0.00154	CcSEcCtD
Regorafenib—Angiopathy—Dexamethasone—ulcerative colitis	0.000189	0.00153	CcSEcCtD
Regorafenib—Angiopathy—Betamethasone—ulcerative colitis	0.000189	0.00153	CcSEcCtD
Regorafenib—Rash—Budesonide—ulcerative colitis	0.000189	0.00153	CcSEcCtD
Regorafenib—Dermatitis—Budesonide—ulcerative colitis	0.000189	0.00153	CcSEcCtD
Regorafenib—Headache—Budesonide—ulcerative colitis	0.000188	0.00152	CcSEcCtD
Regorafenib—Hypertension—Prednisolone—ulcerative colitis	0.000188	0.00152	CcSEcCtD
Regorafenib—Alopecia—Betamethasone—ulcerative colitis	0.000184	0.00149	CcSEcCtD
Regorafenib—Alopecia—Dexamethasone—ulcerative colitis	0.000184	0.00149	CcSEcCtD
Regorafenib—Hypertension—Hydrocortisone—ulcerative colitis	0.000183	0.00148	CcSEcCtD
Regorafenib—Diarrhoea—Azathioprine—ulcerative colitis	0.000183	0.00148	CcSEcCtD
Regorafenib—Haemoglobin—Prednisone—ulcerative colitis	0.000183	0.00148	CcSEcCtD
Regorafenib—Haemorrhage—Prednisone—ulcerative colitis	0.000182	0.00147	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00018	0.00145	CcSEcCtD
Regorafenib—Connective tissue disorder—Prednisone—ulcerative colitis	0.000178	0.00144	CcSEcCtD
Regorafenib—Nausea—Budesonide—ulcerative colitis	0.000178	0.00144	CcSEcCtD
Regorafenib—Asthenia—Mesalazine—ulcerative colitis	0.000175	0.00142	CcSEcCtD
Regorafenib—Hypertension—Triamcinolone—ulcerative colitis	0.000173	0.0014	CcSEcCtD
Regorafenib—Hypertension—Methylprednisolone—ulcerative colitis	0.000172	0.00139	CcSEcCtD
Regorafenib—Infection—Hydrocortisone—ulcerative colitis	0.000172	0.00139	CcSEcCtD
Regorafenib—Vomiting—Azathioprine—ulcerative colitis	0.00017	0.00138	CcSEcCtD
Regorafenib—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.00017	0.00138	CcSEcCtD
Regorafenib—Rash—Azathioprine—ulcerative colitis	0.000169	0.00137	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000169	0.00137	CcSEcCtD
Regorafenib—Dermatitis—Azathioprine—ulcerative colitis	0.000169	0.00136	CcSEcCtD
Regorafenib—Skin disorder—Hydrocortisone—ulcerative colitis	0.000168	0.00136	CcSEcCtD
Regorafenib—Headache—Azathioprine—ulcerative colitis	0.000168	0.00136	CcSEcCtD
Regorafenib—Diarrhoea—Mesalazine—ulcerative colitis	0.000167	0.00135	CcSEcCtD
Regorafenib—Dry mouth—Triamcinolone—ulcerative colitis	0.000167	0.00135	CcSEcCtD
Regorafenib—Angiopathy—Prednisone—ulcerative colitis	0.000165	0.00133	CcSEcCtD
Regorafenib—Infection—Triamcinolone—ulcerative colitis	0.000162	0.00131	CcSEcCtD
Regorafenib—Infection—Methylprednisolone—ulcerative colitis	0.000162	0.00131	CcSEcCtD
Regorafenib—Alopecia—Prednisone—ulcerative colitis	0.00016	0.0013	CcSEcCtD
Regorafenib—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.00016	0.00129	CcSEcCtD
Regorafenib—Nausea—Azathioprine—ulcerative colitis	0.000159	0.00129	CcSEcCtD
Regorafenib—Skin disorder—Methylprednisolone—ulcerative colitis	0.000158	0.00128	CcSEcCtD
Regorafenib—Malnutrition—Prednisone—ulcerative colitis	0.000158	0.00128	CcSEcCtD
Regorafenib—Hypertension—Dexamethasone—ulcerative colitis	0.000157	0.00127	CcSEcCtD
Regorafenib—Hypertension—Betamethasone—ulcerative colitis	0.000157	0.00127	CcSEcCtD
Regorafenib—Vomiting—Mesalazine—ulcerative colitis	0.000155	0.00125	CcSEcCtD
Regorafenib—Rash—Mesalazine—ulcerative colitis	0.000154	0.00124	CcSEcCtD
Regorafenib—Dermatitis—Mesalazine—ulcerative colitis	0.000154	0.00124	CcSEcCtD
Regorafenib—Headache—Mesalazine—ulcerative colitis	0.000153	0.00124	CcSEcCtD
Regorafenib—Pain—Prednisolone—ulcerative colitis	0.000152	0.00123	CcSEcCtD
Regorafenib—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000151	0.00122	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.00015	0.00121	CcSEcCtD
Regorafenib—Fatigue—Hydrocortisone—ulcerative colitis	0.000149	0.00121	CcSEcCtD
Regorafenib—Pain—Hydrocortisone—ulcerative colitis	0.000148	0.0012	CcSEcCtD
Regorafenib—Infection—Dexamethasone—ulcerative colitis	0.000147	0.00119	CcSEcCtD
Regorafenib—Infection—Betamethasone—ulcerative colitis	0.000147	0.00119	CcSEcCtD
Regorafenib—Anaemia—Prednisone—ulcerative colitis	0.000146	0.00118	CcSEcCtD
Regorafenib—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000145	0.00118	CcSEcCtD
Regorafenib—Nervous system disorder—Betamethasone—ulcerative colitis	0.000145	0.00118	CcSEcCtD
Regorafenib—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000145	0.00117	CcSEcCtD
Regorafenib—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000145	0.00117	CcSEcCtD
Regorafenib—Nausea—Mesalazine—ulcerative colitis	0.000145	0.00117	CcSEcCtD
Regorafenib—ABCB1—liver—ulcerative colitis	0.000145	0.00145	CbGeAlD
Regorafenib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000142	0.00115	CcSEcCtD
Regorafenib—Fatigue—Triamcinolone—ulcerative colitis	0.000141	0.00114	CcSEcCtD
Regorafenib—Fatigue—Methylprednisolone—ulcerative colitis	0.00014	0.00114	CcSEcCtD
Regorafenib—Pain—Triamcinolone—ulcerative colitis	0.00014	0.00113	CcSEcCtD
Regorafenib—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000137	0.00111	CcSEcCtD
Regorafenib—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000137	0.00111	CcSEcCtD
Regorafenib—Hypertension—Prednisone—ulcerative colitis	0.000136	0.0011	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000134	0.00108	CcSEcCtD
Regorafenib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000133	0.00108	CcSEcCtD
Regorafenib—Body temperature increased—Triamcinolone—ulcerative colitis	0.000129	0.00104	CcSEcCtD
Regorafenib—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000129	0.00104	CcSEcCtD
Regorafenib—Decreased appetite—Betamethasone—ulcerative colitis	0.000129	0.00104	CcSEcCtD
Regorafenib—Decreased appetite—Dexamethasone—ulcerative colitis	0.000129	0.00104	CcSEcCtD
Regorafenib—Infection—Prednisone—ulcerative colitis	0.000128	0.00104	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000128	0.00103	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000128	0.00103	CcSEcCtD
Regorafenib—Fatigue—Dexamethasone—ulcerative colitis	0.000128	0.00103	CcSEcCtD
Regorafenib—Fatigue—Betamethasone—ulcerative colitis	0.000128	0.00103	CcSEcCtD
Regorafenib—Pain—Dexamethasone—ulcerative colitis	0.000127	0.00102	CcSEcCtD
Regorafenib—Pain—Betamethasone—ulcerative colitis	0.000127	0.00102	CcSEcCtD
Regorafenib—Nervous system disorder—Prednisone—ulcerative colitis	0.000127	0.00102	CcSEcCtD
Regorafenib—Skin disorder—Prednisone—ulcerative colitis	0.000125	0.00101	CcSEcCtD
Regorafenib—Asthenia—Hydrocortisone—ulcerative colitis	0.000124	0.00101	CcSEcCtD
Regorafenib—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000121	0.00098	CcSEcCtD
Regorafenib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000121	0.00098	CcSEcCtD
Regorafenib—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000119	0.00096	CcSEcCtD
Regorafenib—Asthenia—Triamcinolone—ulcerative colitis	0.000117	0.000948	CcSEcCtD
Regorafenib—Abdominal pain—Dexamethasone—ulcerative colitis	0.000117	0.000947	CcSEcCtD
Regorafenib—Body temperature increased—Dexamethasone—ulcerative colitis	0.000117	0.000947	CcSEcCtD
Regorafenib—Body temperature increased—Betamethasone—ulcerative colitis	0.000117	0.000947	CcSEcCtD
Regorafenib—Abdominal pain—Betamethasone—ulcerative colitis	0.000117	0.000947	CcSEcCtD
Regorafenib—Asthenia—Methylprednisolone—ulcerative colitis	0.000117	0.000946	CcSEcCtD
Regorafenib—Decreased appetite—Prednisone—ulcerative colitis	0.000112	0.000907	CcSEcCtD
Regorafenib—Rash—Prednisolone—ulcerative colitis	0.000112	0.000906	CcSEcCtD
Regorafenib—Dermatitis—Prednisolone—ulcerative colitis	0.000112	0.000905	CcSEcCtD
Regorafenib—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000111	0.000902	CcSEcCtD
Regorafenib—Fatigue—Prednisone—ulcerative colitis	0.000111	0.0009	CcSEcCtD
Regorafenib—Headache—Prednisolone—ulcerative colitis	0.000111	0.0009	CcSEcCtD
Regorafenib—Vomiting—Hydrocortisone—ulcerative colitis	0.00011	0.000892	CcSEcCtD
Regorafenib—Rash—Hydrocortisone—ulcerative colitis	0.000109	0.000884	CcSEcCtD
Regorafenib—Dermatitis—Hydrocortisone—ulcerative colitis	0.000109	0.000884	CcSEcCtD
Regorafenib—Headache—Hydrocortisone—ulcerative colitis	0.000109	0.000879	CcSEcCtD
Regorafenib—Asthenia—Dexamethasone—ulcerative colitis	0.000106	0.00086	CcSEcCtD
Regorafenib—Asthenia—Betamethasone—ulcerative colitis	0.000106	0.00086	CcSEcCtD
Regorafenib—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000105	0.000853	CcSEcCtD
Regorafenib—Nausea—Prednisolone—ulcerative colitis	0.000105	0.000853	CcSEcCtD
Regorafenib—Vomiting—Triamcinolone—ulcerative colitis	0.000104	0.00084	CcSEcCtD
Regorafenib—Vomiting—Methylprednisolone—ulcerative colitis	0.000104	0.000838	CcSEcCtD
Regorafenib—Nausea—Hydrocortisone—ulcerative colitis	0.000103	0.000833	CcSEcCtD
Regorafenib—Rash—Triamcinolone—ulcerative colitis	0.000103	0.000833	CcSEcCtD
Regorafenib—Dermatitis—Triamcinolone—ulcerative colitis	0.000103	0.000832	CcSEcCtD
Regorafenib—Rash—Methylprednisolone—ulcerative colitis	0.000103	0.000831	CcSEcCtD
Regorafenib—Dermatitis—Methylprednisolone—ulcerative colitis	0.000103	0.00083	CcSEcCtD
Regorafenib—Headache—Triamcinolone—ulcerative colitis	0.000102	0.000827	CcSEcCtD
Regorafenib—Headache—Methylprednisolone—ulcerative colitis	0.000102	0.000826	CcSEcCtD
Regorafenib—Abdominal pain—Prednisone—ulcerative colitis	0.000102	0.000825	CcSEcCtD
Regorafenib—Body temperature increased—Prednisone—ulcerative colitis	0.000102	0.000825	CcSEcCtD
Regorafenib—Diarrhoea—Dexamethasone—ulcerative colitis	0.000101	0.00082	CcSEcCtD
Regorafenib—Diarrhoea—Betamethasone—ulcerative colitis	0.000101	0.00082	CcSEcCtD
Regorafenib—Nausea—Triamcinolone—ulcerative colitis	9.7e-05	0.000785	CcSEcCtD
Regorafenib—Nausea—Methylprednisolone—ulcerative colitis	9.68e-05	0.000783	CcSEcCtD
Regorafenib—Vomiting—Dexamethasone—ulcerative colitis	9.42e-05	0.000762	CcSEcCtD
Regorafenib—Vomiting—Betamethasone—ulcerative colitis	9.42e-05	0.000762	CcSEcCtD
Regorafenib—Rash—Betamethasone—ulcerative colitis	9.34e-05	0.000756	CcSEcCtD
Regorafenib—Rash—Dexamethasone—ulcerative colitis	9.34e-05	0.000756	CcSEcCtD
Regorafenib—Dermatitis—Betamethasone—ulcerative colitis	9.33e-05	0.000755	CcSEcCtD
Regorafenib—Dermatitis—Dexamethasone—ulcerative colitis	9.33e-05	0.000755	CcSEcCtD
Regorafenib—Headache—Betamethasone—ulcerative colitis	9.28e-05	0.000751	CcSEcCtD
Regorafenib—Headache—Dexamethasone—ulcerative colitis	9.28e-05	0.000751	CcSEcCtD
Regorafenib—Asthenia—Prednisone—ulcerative colitis	9.26e-05	0.000749	CcSEcCtD
Regorafenib—Diarrhoea—Prednisone—ulcerative colitis	8.83e-05	0.000714	CcSEcCtD
Regorafenib—Nausea—Dexamethasone—ulcerative colitis	8.8e-05	0.000712	CcSEcCtD
Regorafenib—Nausea—Betamethasone—ulcerative colitis	8.8e-05	0.000712	CcSEcCtD
Regorafenib—Vomiting—Prednisone—ulcerative colitis	8.2e-05	0.000664	CcSEcCtD
Regorafenib—Rash—Prednisone—ulcerative colitis	8.13e-05	0.000658	CcSEcCtD
Regorafenib—Dermatitis—Prednisone—ulcerative colitis	8.13e-05	0.000657	CcSEcCtD
Regorafenib—Headache—Prednisone—ulcerative colitis	8.08e-05	0.000654	CcSEcCtD
Regorafenib—Nausea—Prednisone—ulcerative colitis	7.66e-05	0.00062	CcSEcCtD
Regorafenib—Sorafenib—ABCB1—ulcerative colitis	6.58e-05	1	CrCbGaD
Regorafenib—PDGFRB—Immune System—JAK2—ulcerative colitis	7.45e-06	4.1e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TGFB1—ulcerative colitis	7.45e-06	4.1e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IFNG—ulcerative colitis	7.32e-06	4.03e-05	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—IL6—ulcerative colitis	7.3e-06	4.02e-05	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	7.3e-06	4.02e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—JAK2—ulcerative colitis	7.29e-06	4.01e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—IL6—ulcerative colitis	7.28e-06	4.01e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—JAK2—ulcerative colitis	7.27e-06	4e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—NFKB1—ulcerative colitis	7.27e-06	4e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—JAK2—ulcerative colitis	7.26e-06	4e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL1B—ulcerative colitis	7.26e-06	4e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CALM3—ulcerative colitis	7.26e-06	4e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CD4—ulcerative colitis	7.26e-06	4e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL1B—ulcerative colitis	7.24e-06	3.99e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CD4—ulcerative colitis	7.24e-06	3.99e-05	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—IL6—ulcerative colitis	7.24e-06	3.98e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL2—ulcerative colitis	7.23e-06	3.98e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—RELA—ulcerative colitis	7.22e-06	3.97e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL2—ulcerative colitis	7.22e-06	3.97e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PTGS2—ulcerative colitis	7.21e-06	3.97e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PTGS2—ulcerative colitis	7.19e-06	3.96e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ADCY5—ulcerative colitis	7.19e-06	3.96e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—NFKB1—ulcerative colitis	7.14e-06	3.93e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IFNG—ulcerative colitis	7.13e-06	3.92e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—STAT3—ulcerative colitis	7.11e-06	3.92e-05	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—TP53—ulcerative colitis	7.1e-06	3.91e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD4—ulcerative colitis	7.07e-06	3.89e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—RELA—ulcerative colitis	7.06e-06	3.89e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CXCL8—ulcerative colitis	7.04e-06	3.87e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—RELA—ulcerative colitis	7.03e-06	3.87e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—ADCY5—ulcerative colitis	6.89e-06	3.79e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD4—ulcerative colitis	6.89e-06	3.79e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—JAK2—ulcerative colitis	6.88e-06	3.79e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGS1—ulcerative colitis	6.83e-06	3.76e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—NFKB1—ulcerative colitis	6.77e-06	3.73e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—NFKB1—ulcerative colitis	6.76e-06	3.72e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL2—ulcerative colitis	6.73e-06	3.7e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.72e-06	3.7e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.67e-06	3.67e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CXCL8—ulcerative colitis	6.65e-06	3.66e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—JAK2—ulcerative colitis	6.64e-06	3.66e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CXCL8—ulcerative colitis	6.64e-06	3.65e-05	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—IL6—ulcerative colitis	6.62e-06	3.64e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—IL6—ulcerative colitis	6.56e-06	3.61e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—STAT3—ulcerative colitis	6.53e-06	3.6e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL1B—ulcerative colitis	6.53e-06	3.59e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CD4—ulcerative colitis	6.52e-06	3.59e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IFNG—ulcerative colitis	6.52e-06	3.59e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—STAT3—ulcerative colitis	6.51e-06	3.58e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL2—ulcerative colitis	6.5e-06	3.58e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PTGS2—ulcerative colitis	6.48e-06	3.56e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—RELA—ulcerative colitis	6.43e-06	3.54e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—STAT3—ulcerative colitis	6.41e-06	3.53e-05	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—IL6—ulcerative colitis	6.39e-06	3.52e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MMP9—ulcerative colitis	6.37e-06	3.5e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL1B—ulcerative colitis	6.36e-06	3.5e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL2—ulcerative colitis	6.36e-06	3.5e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL2—ulcerative colitis	6.34e-06	3.49e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL2—ulcerative colitis	6.34e-06	3.49e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PPARG—ulcerative colitis	6.32e-06	3.48e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PPARG—ulcerative colitis	6.32e-06	3.48e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NFKB1—ulcerative colitis	6.3e-06	3.47e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD4—ulcerative colitis	6.3e-06	3.47e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—JAK2—ulcerative colitis	6.27e-06	3.45e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—JAK2—ulcerative colitis	6.21e-06	3.42e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CALM3—ulcerative colitis	6.15e-06	3.38e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TP53—ulcerative colitis	6.13e-06	3.38e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—JAK2—ulcerative colitis	6.13e-06	3.38e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGS1—ulcerative colitis	6.09e-06	3.35e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—STAT3—ulcerative colitis	6.09e-06	3.35e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—NFKB1—ulcerative colitis	6.09e-06	3.35e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.08e-06	3.35e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—STAT3—ulcerative colitis	6.07e-06	3.34e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—RELA—ulcerative colitis	6.07e-06	3.34e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—TGFB1—ulcerative colitis	6.03e-06	3.32e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—STAT3—ulcerative colitis	6.03e-06	3.32e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MMP9—ulcerative colitis	6.02e-06	3.31e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—RELA—ulcerative colitis	6.01e-06	3.31e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.99e-06	3.3e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NFKB1—ulcerative colitis	5.95e-06	3.28e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGS1—ulcerative colitis	5.95e-06	3.27e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—NFKB1—ulcerative colitis	5.93e-06	3.27e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—STAT3—ulcerative colitis	5.92e-06	3.26e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.88e-06	3.23e-05	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—IL6—ulcerative colitis	5.85e-06	3.22e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL1B—ulcerative colitis	5.82e-06	3.2e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—CD4—ulcerative colitis	5.81e-06	3.2e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL2—ulcerative colitis	5.79e-06	3.19e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—PTGS2—ulcerative colitis	5.77e-06	3.18e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—JAK2—ulcerative colitis	5.75e-06	3.17e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CXCL8—ulcerative colitis	5.72e-06	3.15e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ALB—ulcerative colitis	5.68e-06	3.13e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ALB—ulcerative colitis	5.68e-06	3.13e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CXCL8—ulcerative colitis	5.67e-06	3.12e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—STAT3—ulcerative colitis	5.66e-06	3.12e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—JAK2—ulcerative colitis	5.65e-06	3.11e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ABCB1—ulcerative colitis	5.65e-06	3.11e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—STAT3—ulcerative colitis	5.62e-06	3.09e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL6—ulcerative colitis	5.62e-06	3.09e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—STAT3—ulcerative colitis	5.61e-06	3.09e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—TGFB1—ulcerative colitis	5.59e-06	3.08e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—RELA—ulcerative colitis	5.57e-06	3.07e-05	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.56e-06	3.06e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGS1—ulcerative colitis	5.56e-06	3.06e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—TGFB1—ulcerative colitis	5.49e-06	3.02e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CALM3—ulcerative colitis	5.49e-06	3.02e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—RELA—ulcerative colitis	5.47e-06	3.01e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—STAT3—ulcerative colitis	5.47e-06	3.01e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL2—ulcerative colitis	5.47e-06	3.01e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.47e-06	3.01e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—NFKB1—ulcerative colitis	5.43e-06	2.99e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL2—ulcerative colitis	5.41e-06	2.98e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—JAK2—ulcerative colitis	5.36e-06	2.95e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PPARG—ulcerative colitis	5.36e-06	2.95e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CALM3—ulcerative colitis	5.36e-06	2.95e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—JAK2—ulcerative colitis	5.35e-06	2.94e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—STAT3—ulcerative colitis	5.35e-06	2.94e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—STAT3—ulcerative colitis	5.33e-06	2.93e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ADCY5—ulcerative colitis	5.27e-06	2.9e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CXCL8—ulcerative colitis	5.25e-06	2.89e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TGFB1—ulcerative colitis	5.25e-06	2.89e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.24e-06	2.89e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—TGFB1—ulcerative colitis	5.21e-06	2.87e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—TGFB1—ulcerative colitis	5.2e-06	2.86e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—RELA—ulcerative colitis	5.19e-06	2.86e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—RELA—ulcerative colitis	5.18e-06	2.85e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MMP9—ulcerative colitis	5.17e-06	2.85e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CXCL8—ulcerative colitis	5.16e-06	2.84e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MMP9—ulcerative colitis	5.12e-06	2.82e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NFKB1—ulcerative colitis	5.12e-06	2.82e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NFKB1—ulcerative colitis	5.07e-06	2.79e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—STAT3—ulcerative colitis	5.05e-06	2.78e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL2—ulcerative colitis	5.02e-06	2.76e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CALM3—ulcerative colitis	5e-06	2.75e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL6—ulcerative colitis	4.97e-06	2.74e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTGS2—ulcerative colitis	4.97e-06	2.74e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTGS2—ulcerative colitis	4.97e-06	2.74e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TGFB1—ulcerative colitis	4.96e-06	2.73e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL2—ulcerative colitis	4.93e-06	2.71e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CXCL8—ulcerative colitis	4.89e-06	2.69e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CXCL8—ulcerative colitis	4.88e-06	2.69e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—STAT3—ulcerative colitis	4.88e-06	2.68e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ALB—ulcerative colitis	4.82e-06	2.65e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—JAK2—ulcerative colitis	4.82e-06	2.65e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.78e-06	2.63e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ABCB1—ulcerative colitis	4.78e-06	2.63e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MMP9—ulcerative colitis	4.75e-06	2.61e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NFKB1—ulcerative colitis	4.7e-06	2.59e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—TGFB1—ulcerative colitis	4.68e-06	2.58e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL2—ulcerative colitis	4.68e-06	2.57e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—RELA—ulcerative colitis	4.67e-06	2.57e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL2—ulcerative colitis	4.67e-06	2.57e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MMP9—ulcerative colitis	4.66e-06	2.57e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NFKB1—ulcerative colitis	4.62e-06	2.54e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—STAT3—ulcerative colitis	4.6e-06	2.53e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL6—ulcerative colitis	4.56e-06	2.51e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—STAT3—ulcerative colitis	4.56e-06	2.51e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—IL6—ulcerative colitis	4.54e-06	2.5e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—STAT3—ulcerative colitis	4.5e-06	2.48e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL6—ulcerative colitis	4.48e-06	2.47e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ADCY5—ulcerative colitis	4.46e-06	2.46e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MMP9—ulcerative colitis	4.43e-06	2.44e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MMP9—ulcerative colitis	4.42e-06	2.43e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CXCL8—ulcerative colitis	4.4e-06	2.42e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NFKB1—ulcerative colitis	4.38e-06	2.41e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NFKB1—ulcerative colitis	4.37e-06	2.4e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TP53—ulcerative colitis	4.32e-06	2.38e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—JAK2—ulcerative colitis	4.3e-06	2.36e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ABCB1—ulcerative colitis	4.27e-06	2.35e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TGFB1—ulcerative colitis	4.26e-06	2.35e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL6—ulcerative colitis	4.25e-06	2.34e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL6—ulcerative colitis	4.24e-06	2.33e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TGFB1—ulcerative colitis	4.22e-06	2.33e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—STAT3—ulcerative colitis	4.22e-06	2.32e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTGS2—ulcerative colitis	4.22e-06	2.32e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—IL6—ulcerative colitis	4.21e-06	2.32e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL2—ulcerative colitis	4.2e-06	2.31e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—TGFB1—ulcerative colitis	4.17e-06	2.3e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—RELA—ulcerative colitis	4.16e-06	2.29e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—STAT3—ulcerative colitis	4.15e-06	2.28e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—IL6—ulcerative colitis	4.14e-06	2.28e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TP53—ulcerative colitis	4.08e-06	2.25e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ADCY5—ulcerative colitis	3.98e-06	2.19e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP9—ulcerative colitis	3.98e-06	2.19e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL6—ulcerative colitis	3.95e-06	2.18e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—STAT3—ulcerative colitis	3.94e-06	2.17e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NFKB1—ulcerative colitis	3.94e-06	2.17e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PPARG—ulcerative colitis	3.93e-06	2.16e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—IL6—ulcerative colitis	3.93e-06	2.16e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—STAT3—ulcerative colitis	3.93e-06	2.16e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CXCL8—ulcerative colitis	3.92e-06	2.16e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—IL6—ulcerative colitis	3.92e-06	2.16e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TGFB1—ulcerative colitis	3.91e-06	2.15e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ABCB1—ulcerative colitis	3.89e-06	2.14e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ADCY5—ulcerative colitis	3.89e-06	2.14e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TGFB1—ulcerative colitis	3.84e-06	2.12e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL6—ulcerative colitis	3.82e-06	2.1e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2—ulcerative colitis	3.75e-06	2.06e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL6—ulcerative colitis	3.74e-06	2.06e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL6—ulcerative colitis	3.73e-06	2.05e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL6—ulcerative colitis	3.72e-06	2.05e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	3.66e-06	2.02e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TGFB1—ulcerative colitis	3.65e-06	2.01e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TGFB1—ulcerative colitis	3.64e-06	2e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ADCY5—ulcerative colitis	3.63e-06	2e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP9—ulcerative colitis	3.55e-06	1.95e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—STAT3—ulcerative colitis	3.54e-06	1.95e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ALB—ulcerative colitis	3.53e-06	1.94e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—IL6—ulcerative colitis	3.53e-06	1.94e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TP53—ulcerative colitis	3.51e-06	1.93e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NFKB1—ulcerative colitis	3.51e-06	1.93e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TP53—ulcerative colitis	3.48e-06	1.91e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL6—ulcerative colitis	3.41e-06	1.87e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PPARG—ulcerative colitis	3.33e-06	1.83e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.3e-06	1.82e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TGFB1—ulcerative colitis	3.28e-06	1.8e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TP53—ulcerative colitis	3.22e-06	1.77e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL6—ulcerative colitis	3.21e-06	1.77e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL6—ulcerative colitis	3.18e-06	1.75e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TP53—ulcerative colitis	3.16e-06	1.74e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—STAT3—ulcerative colitis	3.15e-06	1.74e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—IL6—ulcerative colitis	3.14e-06	1.73e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTGS2—ulcerative colitis	3.09e-06	1.7e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TP53—ulcerative colitis	3e-06	1.65e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TP53—ulcerative colitis	3e-06	1.65e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ALB—ulcerative colitis	2.99e-06	1.65e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PPARG—ulcerative colitis	2.97e-06	1.63e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL6—ulcerative colitis	2.95e-06	1.62e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TGFB1—ulcerative colitis	2.92e-06	1.61e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PPARG—ulcerative colitis	2.9e-06	1.6e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL6—ulcerative colitis	2.9e-06	1.59e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL6—ulcerative colitis	2.75e-06	1.51e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL6—ulcerative colitis	2.74e-06	1.51e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPARG—ulcerative colitis	2.71e-06	1.49e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TP53—ulcerative colitis	2.7e-06	1.49e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ALB—ulcerative colitis	2.67e-06	1.47e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGS2—ulcerative colitis	2.62e-06	1.44e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ALB—ulcerative colitis	2.61e-06	1.43e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.57e-06	1.41e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6—ulcerative colitis	2.47e-06	1.36e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ALB—ulcerative colitis	2.43e-06	1.34e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TP53—ulcerative colitis	2.41e-06	1.32e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.39e-06	1.32e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGS2—ulcerative colitis	2.34e-06	1.29e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.28e-06	1.25e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6—ulcerative colitis	2.2e-06	1.21e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGS2—ulcerative colitis	2.13e-06	1.17e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.79e-06	9.83e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALB—ulcerative colitis	1.61e-06	8.84e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.4e-06	7.73e-06	CbGpPWpGaD
